Usages in wwPDB of concept: c_0322
nUsages: 192; SSE string: HHEEHHHHH
1nav:A   (CYS244) to   (GLU391)  THYROID RECEPTOR ALPHA IN COMPLEX WITH AN AGONIST SELECTIVE FOR THYROID RECEPTOR BETA1  |   NUCLEAR RECEPTOR, THYROID RECEPTOR, LIGAND, COMPLEX, MEMBRANE PROTEIN 
1nax:A   (PRO297) to   (GLU445)  THYROID RECEPTOR BETA1 IN COMPLEX WITH A BETA-SELECTIVE LIGAND  |   NUCLEAR RECEPTOR, THYROID RECEPTOR, COMPLEX, MEMBRANE PROTEIN 
4whf:B   (SER100) to   (ASP249)  CRYSTAL STRUCTURE OF TR3 LBD IN COMPLEX WITH 1-(3,4,5- TRIHYDROXYPHENYL)DECAN-1-ONE  |   LBD, TRANSCRIPTION 
2ayr:A   (THR371) to   (MET528)  A SERM DESIGNED FOR THE TREATMENT OF UTERINE LEIOMYOMA WITH UNIQUE TISSUE SPECIFICITY FOR UTERUS AND OVARIES IN RATS  |   RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, LIGAND- BINDING, SERM 
1nrl:B   (PRO268) to   (PRO419)  CRYSTAL STRUCTURE OF THE HUMAN PXR-LBD IN COMPLEX WITH AN SRC-1 COACTIVATOR PEPTIDE AND SR12813  |   NUCLEAR RECEPTOR, COACTIVATOR, PXR, XENOBIOTIC, SRC-1, LIGAND BINDING DOMAIN, TRANSCRIPTION 
2p7a:A   (SER293) to   (THR420)  CRYSTAL STRUCTURE OF ESTROGEN RELATED RECEPTOR G IN COMPLEX WITH 3-METHYL PHENOL  |   THREE LAYERED ALPHA HELICAL SANDWICH, HORMONE RECEPTOR 
3eyb:A   (PRO322) to   (HIS464)  STRUCTURAL AND FUNCTIONAL INSIGHTS INTO THE LIGAND BINDING DOMAIN OF A NON-DUPLICATED RXR FROM THE INVERTEBRATE CHORDATE AMPHIOXUS  |   AMPHIOXUS, RETINOID X RECEPTOR, NUCLEAR RECEPTOR, LIGAND BINDING, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER, STRUCTURAL GENOMICS, STRUCTURAL PROTEOMICS IN EUROPE, SPINE 
3eyb:C   (PRO322) to   (HIS464)  STRUCTURAL AND FUNCTIONAL INSIGHTS INTO THE LIGAND BINDING DOMAIN OF A NON-DUPLICATED RXR FROM THE INVERTEBRATE CHORDATE AMPHIOXUS  |   AMPHIOXUS, RETINOID X RECEPTOR, NUCLEAR RECEPTOR, LIGAND BINDING, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER, STRUCTURAL GENOMICS, STRUCTURAL PROTEOMICS IN EUROPE, SPINE 
3eyb:D   (PRO322) to   (HIS464)  STRUCTURAL AND FUNCTIONAL INSIGHTS INTO THE LIGAND BINDING DOMAIN OF A NON-DUPLICATED RXR FROM THE INVERTEBRATE CHORDATE AMPHIOXUS  |   AMPHIOXUS, RETINOID X RECEPTOR, NUCLEAR RECEPTOR, LIGAND BINDING, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER, STRUCTURAL GENOMICS, STRUCTURAL PROTEOMICS IN EUROPE, SPINE 
4x1f:A   (PRO268) to   (ASP416)  CRYSTAL STRUCTURE OF THE HPXR-LBD IN COMPLEX WITH THE SYNTHETIC ESTROGEN 17ALPHA-ETHINYLESTRADIOL  |   NUCLEAR RECEPTOR, HORMONE RECEPTOR, PREGNANE X RECEPTOR, ESTROGEN, GENE REGULATION 
3f5c:A   (VAL390) to   (GLY543)  STRUCTURE OF DAX-1:LRH-1 COMPLEX  |   NUCLEAR RECEPTOR, TRANSCRIPTIONAL COREPRESSOR, REGULATORY COMPLEX, DNA-BINDING, LIPID-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, CYTOPLASM, REPRESSOR 
3fal:B   (SER280) to   (ASP430)  HUMANRXR ALPHA & MOUSE LXR ALPHA COMPLEXED WITH RETENOIC ACID AND GSK2186  |   NUCLEAR HORMONE RECEPTOR NONSTEROIDAL LXR AGONIST CHOLOESTOROL METABOLISM, DNA-BINDING, HOST-VIRUS INTERACTION, METAL-BINDING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, UBL CONJUGATION, ZINC, ZINC-FINGER, SIGNALING PROTEIN 
2pjl:A   (SER349) to   (LYS499)  CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR ALPHA IN COMPLEX WITH A SYNTHETIC INVERSE AGONIST REVEALS ITS NOVEL MOLECULAR MECHANISM  |   NUCLEAR HORMONE RECEPTOR, LIGAND BINDING DOMAIN, LIGAND BINDING POCKET, THREE-LAYERED ALPHA-HELICAL SANDWICH, INVERSE AGONIST, HELIX 12 (H12), COACTIVATOR GROOVE, TRANSCRIPTION 
2pjl:B   (SER349) to   (LEU479)  CRYSTAL STRUCTURE OF HUMAN ESTROGEN-RELATED RECEPTOR ALPHA IN COMPLEX WITH A SYNTHETIC INVERSE AGONIST REVEALS ITS NOVEL MOLECULAR MECHANISM  |   NUCLEAR HORMONE RECEPTOR, LIGAND BINDING DOMAIN, LIGAND BINDING POCKET, THREE-LAYERED ALPHA-HELICAL SANDWICH, INVERSE AGONIST, HELIX 12 (H12), COACTIVATOR GROOVE, TRANSCRIPTION 
4xi3:C   (THR371) to   (MET528)  ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH BAZEDOXIFENE  |   ESTROGEN RECEPTOR, SERM, BAZEDOXIFENE, BREAST CANCER, NUCLEAR HORMONE RECEPTOR, SIGNALING PROTEIN 
4xi3:D   (THR371) to   (SER527)  ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH BAZEDOXIFENE  |   ESTROGEN RECEPTOR, SERM, BAZEDOXIFENE, BREAST CANCER, NUCLEAR HORMONE RECEPTOR, SIGNALING PROTEIN 
3fs1:A   (PRO203) to   (LEU331)  CRYSTAL STRUCTURE OF HNF4A LBD IN COMPLEX WITH THE LIGAND AND THE COACTIVATOR PGC-1A FRAGMENT  |   NUCLEAR RECEPTOR, COACTIVATOR, LXXLL MOTIF, MODY, DIABETES, ALTERNATIVE PROMOTER USAGE, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
2q60:A   (PRO168) to   (GLU309)  CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF POLYANDROCARPA MISAKIENSIS RXR IN TETRAMER IN ABSENCE OF LIGAND  |   NUCLEAR RECEPTOR. RXR LIGAND BINDING DOMAIN, APO-TETRAMER, TRANSCRIPTION 
2q60:B   (PRO168) to   (HIS310)  CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF POLYANDROCARPA MISAKIENSIS RXR IN TETRAMER IN ABSENCE OF LIGAND  |   NUCLEAR RECEPTOR. RXR LIGAND BINDING DOMAIN, APO-TETRAMER, TRANSCRIPTION 
2q60:C   (PRO168) to   (HIS310)  CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF POLYANDROCARPA MISAKIENSIS RXR IN TETRAMER IN ABSENCE OF LIGAND  |   NUCLEAR RECEPTOR. RXR LIGAND BINDING DOMAIN, APO-TETRAMER, TRANSCRIPTION 
2q60:D   (PRO168) to   (LEU308)  CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF POLYANDROCARPA MISAKIENSIS RXR IN TETRAMER IN ABSENCE OF LIGAND  |   NUCLEAR RECEPTOR. RXR LIGAND BINDING DOMAIN, APO-TETRAMER, TRANSCRIPTION 
2q6j:A   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED TO A B-N SUBSTITUTED LIGAND  |   PROTEIN-LIGAND COMPLEX, TRANSCRIPTION 
2qa6:B   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA MUTANT 537S COMPLEXED WITH 4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL  |   PROTEIN-LIGAND COMPLEX, TRANSCRIPTION 
2qa8:B   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN MUTANT 537S COMPLEXED WITH GENISTEIN  |   PROTEIN-LIGAND COMPLEX, TRANSCRIPTION 
2qe4:B   (THR371) to   (MET528)  ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A BENZOPYRAN AGONIST  |   NUCLEAR RECEPTOR, LIGAND-BINDING DOMAIN, ALTERNATIVE SPLICING, DNA-BINDING, LIPID-BINDING, METAL-BINDING, NUCLEAR PROTEIN, PHOSPHORYLATION, POLYMORPHISM, STEROID- BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
1pcg:A   (THR371) to   (ASN532)  HELIX-STABILIZED CYCLIC PEPTIDES AS SELECTIVE INHIBITORS OF STEROID RECEPTOR-COACTIVATOR INTERACTIONS  |   CO-ACTIVATOR BINDING SITE, TRANSCRIPTION-INHIBITOR COMPLEX 
1pcg:B   (THR371) to   (ASN532)  HELIX-STABILIZED CYCLIC PEPTIDES AS SELECTIVE INHIBITORS OF STEROID RECEPTOR-COACTIVATOR INTERACTIONS  |   CO-ACTIVATOR BINDING SITE, TRANSCRIPTION-INHIBITOR COMPLEX 
2qh6:A   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEXED WITH AN OXABICYCLIC DIARYLETHYLENE COMPOUND  |   PROTEIN-LIGAND COMPLEX, TRANSCRIPTION 
4iv4:A   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH CONSTRAINED WAY-DERIVATIVE, 5B  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, TRANSCRIPTION 
4iwf:A   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DYNAMIC OXIME-DERIVATIVE  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, TRANSCRIPTION 
1pq6:C   (GLY296) to   (GLN438)  HUMAN LXR BETA HORMONE RECEPTOR / GW3965 COMPLEX  |   LXRB+KB043546/WAY207380/GW3965, TRANSCRIPTION REGULATION 
1pq9:A   (GLY296) to   (ARG411)  HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 COMPLEX  |   LXRB+T0901317 SPLIT, TRANSCRIPTION REGULATION 
2qw4:A   (SER100) to   (ASP249)  HUMAN NR4A1 LIGAND-BINDING DOMAIN  |   NUCLEAR RECEPTOR, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, DNA-BINDING, METAL-BINDING, NUCLEUS, PHOSPHORYLATION, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC- FINGER, HORMONE RECEPTOR 
2qw4:C   (SER100) to   (ASP249)  HUMAN NR4A1 LIGAND-BINDING DOMAIN  |   NUCLEAR RECEPTOR, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, DNA-BINDING, METAL-BINDING, NUCLEUS, PHOSPHORYLATION, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC- FINGER, HORMONE RECEPTOR 
2r6y:A   (THR371) to   (MET528)  ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A SERM  |   ESTROGEN RECEPTOR, LIGAND-BINDING DOMAIN, ALTERNATIVE SPLICING, DNA-BINDING, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHORYLATION, POLYMORPHISM, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
4jgv:B   (SER431) to   (GLU579)  CRYSTAL STRUCTURE OF HUMAN NUR77 LIGAND-BINDING DOMAIN IN COMPLEX WITH THPN  |   TRANSCRIPTION 
1ere:A   (THR371) to   (ASN532)  HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-ESTRADIOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, STEROID, AGONIST 
1ere:B   (THR371) to   (ASN532)  HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-ESTRADIOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, STEROID, AGONIST 
1ere:E   (THR371) to   (ASN532)  HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-ESTRADIOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, STEROID, AGONIST 
1qku:A   (THR371) to   (ASN532)  WILD TYPE ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL  |   NUCLEAR RECEPTOR, AGONISM, ANTAGONISM, CRYSTAL STRUCTURE, ESTRADIOL RECEPTOR, STEROID, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS 
1qku:B   (THR371) to   (ASN532)  WILD TYPE ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL  |   NUCLEAR RECEPTOR, AGONISM, ANTAGONISM, CRYSTAL STRUCTURE, ESTRADIOL RECEPTOR, STEROID, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS 
1qku:C   (THR371) to   (ASN532)  WILD TYPE ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL  |   NUCLEAR RECEPTOR, AGONISM, ANTAGONISM, CRYSTAL STRUCTURE, ESTRADIOL RECEPTOR, STEROID, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS 
3hlv:B   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE AND 16-ALPHA-HYDROXY-ESTRONE ((8S,9R,13S,14R, 16R)-3,16-DIHYDROXY-13-METHYL-7,8,9,11,12,14,15, 16-OCTAHYDRO-6H- CYCLOPENTA[A]PHENANTHREN-17-ONE  |   ESTROGEN RECEPTOR, LBD, GRIP PEPTIDE, HYDROXY-ESTRONE, ALTERNATIVE SPLICING, DNA-BINDING, GLYCOPROTEIN, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, ACTIVATOR, HORMONE, NUCLEAR RECEPTOR 
2v7c:B   (ILE423) to   (MSE567)  CRYSTAL STRUCTURE OF REV-ERB BETA  |   DNA-BINDING, TRANSCRIPTION, METAL-BINDING, ZINC, NUCLEUS, RECEPTOR, REPRESSOR, ZINC-FINGER, CONSTITUTIVE REPRESSION, TRANSCRIPTION REGULATION, ORPHAN RECEPTOR, A-HELICAL SANDWICH 
1rkh:A   (THR251) to   (GLN403)  CRYSTAL STRUCTURE OF THE RAT VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH 2AM20R AND A SYNTHETIC PEPTIDE CONTAINING THE NR2 BOX OF DRIP 205  |   NUCLEAR RECEPTOR-LIGAND COMPLEX, NUCLEAR RECEPTOR- COACTIVATOR INTERACTIONS, HORMONE/GROWTH FACTOR RECEPTOR COMPLEX 
1g1u:A   (PRO293) to   (GLU434)  THE 2.5 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE RXRALPHA LIGAND BINDING DOMAIN IN TETRAMER IN THE ABSENCE OF LIGAND  |   CRYSTAL STRUCTURE, RXRALPHA LIGAND BINDING DOMAIN, TETRAMER, ABSENCE OF LIGAND, TRANSCRIPTION 
1g50:B  (THR1371) to  (ASN1532)  CRYSTAL STRUCTURE OF A WILD TYPE HER ALPHA LBD AT 2.9 ANGSTROM RESOLUTION  |   ALPHA HELICES, ESTRADIOL, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS, DNA BINDING PROTEIN 
1g50:C  (THR2371) to  (ASN2532)  CRYSTAL STRUCTURE OF A WILD TYPE HER ALPHA LBD AT 2.9 ANGSTROM RESOLUTION  |   ALPHA HELICES, ESTRADIOL, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS, DNA BINDING PROTEIN 
1g5y:A   (PRO293) to   (GLU434)  THE 2.0 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE RXRALPHA LIGAND BINDING DOMAIN TETRAMER IN THE PRESENCE OF A NON-ACTIVATING RETINOIC ACID ISOMER.  |   RXRALPHA LIGAND BINDING DOMAIN, INACTIVE TETRAMER WITH 2 MONOMERS BOUND WITH AN INACTIVATING ISOMER OF RETINOIC ACID, TRANSCRIPTION 
3uud:A   (LEU372) to   (ASN532)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH ESTRADIOL  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
3uud:B   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH ESTRADIOL  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
3uvv:A   (GLU243) to   (CYS390)  CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAINS OF THE THYROID RECEPTOR:RETINOID X RECEPTOR COMPLEXED WITH 3,3',5 TRIIODO-L- THYRONINE AND 9-CIS RETINOIC ACID  |   TR-RXR HETERODIMER, ALLOSTERY, ALPHA HELICAL SANDWICH, TRANSACTIVATION, HORMONE RECEPTOR-HORMONE RECEPTOR COMPLEX 
3hvl:B   (PRO268) to   (PRO419)  TETHERED PXR-LBD/SRC-1P COMPLEXED WITH SR-12813  |   PXR, SRC-1, TETHERED, ENGINEERED, DRUG-DRUG INTERACTIONS, DNA- BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER, TRANSFERASE 
1s9p:B   (SER293) to   (THR420)  CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH DIETHYLSTILBESTROL  |   LIGAND-BINDING DOMAIN, ANTAGONIST COMPLEX, TRANSCRIPTION 
1s9p:C   (SER293) to   (MET419)  CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH DIETHYLSTILBESTROL  |   LIGAND-BINDING DOMAIN, ANTAGONIST COMPLEX, TRANSCRIPTION 
3hzf:A   (GLN247) to   (GLU391)  STRUCTURE OF TR-ALFA BOUND TO SELECTIVE THYROMIMETIC GC-1 IN C2 SPACE GROUP  |   NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC- FINGER 
1gwr:A   (THR371) to   (ASN532)  HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, TRANSACTIVATION, AGONIST, AF2 COACTIVATOR , RECEPTOR, ACTIVATOR, TRANSCRIPTI REGULATION, DNA-BINDING, NUCLEAR PROTEIN, ZINC FINGER, STER BINDING, PHOSPHORYLATION, POLYMORPHISM, ALTERNATIVE SPLICING 
2gl8:A    (THR72) to   (LEU212)  HUMAN RETINOIC ACID RECEPTOR RXR-GAMMA LIGAND-BINDING DOMAIN  |   NUCLEAR RECEPTOR, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
2gl8:B    (THR72) to   (HIS214)  HUMAN RETINOIC ACID RECEPTOR RXR-GAMMA LIGAND-BINDING DOMAIN  |   NUCLEAR RECEPTOR, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
2gl8:D    (THR72) to   (HIS214)  HUMAN RETINOIC ACID RECEPTOR RXR-GAMMA LIGAND-BINDING DOMAIN  |   NUCLEAR RECEPTOR, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX 
4znh:A   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 2-FLUORO-SUBSTITUTED OBHS DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
4znh:B   (THR371) to   (LYS529)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 2-FLUORO-SUBSTITUTED OBHS DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
4znw:B   (THR371) to   (SER527)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 4-BROMO-SUBSTITUTED OBHS DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
4zo1:X   (PRO297) to   (GLU445)  CRYSTAL STRUCTURE OF THE T3-BOUND TR-BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH RXR-ALPHA  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, PROTEIN BINDING 
4zo1:B   (PRO293) to   (HIS435)  CRYSTAL STRUCTURE OF THE T3-BOUND TR-BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH RXR-ALPHA  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, PROTEIN BINDING 
2gpv:B   (SER293) to   (MET419)  ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH 4-HYDROXY-TAMOXIFEN AND A SMRT PEPTIDE  |   ESTROGEN RELATED RECEPTOR, ERR, ERRG, ESRRG, NUCLEAR RECEPTOR, STEROID RECEPTOR, SMRT, TAMOXIFEN, TRANSCRIPTION 
2gpv:C   (SER293) to   (MET419)  ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH 4-HYDROXY-TAMOXIFEN AND A SMRT PEPTIDE  |   ESTROGEN RELATED RECEPTOR, ERR, ERRG, ESRRG, NUCLEAR RECEPTOR, STEROID RECEPTOR, SMRT, TAMOXIFEN, TRANSCRIPTION 
2gpv:D   (SER293) to   (MET419)  ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH 4-HYDROXY-TAMOXIFEN AND A SMRT PEPTIDE  |   ESTROGEN RELATED RECEPTOR, ERR, ERRG, ESRRG, NUCLEAR RECEPTOR, STEROID RECEPTOR, SMRT, TAMOXIFEN, TRANSCRIPTION 
2gpv:F   (SER293) to   (MET419)  ESTROGEN RELATED RECEPTOR-GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH 4-HYDROXY-TAMOXIFEN AND A SMRT PEPTIDE  |   ESTROGEN RELATED RECEPTOR, ERR, ERRG, ESRRG, NUCLEAR RECEPTOR, STEROID RECEPTOR, SMRT, TAMOXIFEN, TRANSCRIPTION 
3ilz:A   (ASP246) to   (HIS387)  STRUCTURE OF TR-ALFA BOUND TO SELECTIVE THYROMIMETIC GC-1 IN P212121 SPACE GROUP  |   NUCLEAR RECEPTOR, SIGNALING PROTEIN 
1tfc:B   (SER293) to   (GLY442)  CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH A STEROID RECEPTOR COACTIVATOR-1 PEPTIDE  |   TRANSCRIPTIONALLY ACTIVE CONFORMATION IN ABSENCE OF LIGAND, TRANSCRIPTION 
3ips:B   (LEU275) to   (ASP432)  X-RAY STRUCTURE OF BENZISOXAZOLE SYNTHETIC AGONIST BOUND TO THE LXR- ALPHA  |   NUCLEAR RECEPTOR, LXR HOMODIMER, LXR SIGNALING, ALTERNATIVE SPLICING, NUCLEUS, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ACTIVATOR, ISOPEPTIDE BOND, PROTO-ONCOGENE, CHOLESTEROL, ABCA1, HETERODIMER, RXR, LIGAND COMPLEX 
1hg4:D   (LYS275) to   (ARG480)  ULTRASPIRACLE LIGAND BINDING DOMAIN FROM DROSOPHILA MELANOGASTER  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING 
1hg4:E   (LYS275) to   (PHE479)  ULTRASPIRACLE LIGAND BINDING DOMAIN FROM DROSOPHILA MELANOGASTER  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING 
2h77:A   (CYS244) to   (ALA379)  CRYSTAL STRUCTURE OF HUMAN TR ALPHA BOUND T3 IN MONOCLINIC SPACE GROUP  |   TR ALPHA, T3, HORMONE/GROWTH FACTOR COMPLEX 
2h79:A   (ASP246) to   (HIS387)  CRYSTAL STRUCTURE OF HUMAN TR ALPHA BOUND T3 IN ORTHORHOMBIC SPACE GROUP  |   TR ALPHA, TR, T3, HORMONE/GROWTH FACTOR COMPLEX 
2has:A   (THR255) to   (SER405)  CRYSTAL STRUCTURE OF VDR LBD IN COMPLEX WITH 2ALPHA-(1- PROPOXY) CALCITRIOL  |   ALPHA HELICAL SANDWICH, GENE REGULATION 
4lnx:A   (ASP246) to   (GLU391)  CRYSTAL STRUCTURE OF TR-ALPHA BOUND TO T4 IN A SECOND SITE  |   MAINLY ALPHA ORTHOGONAL BUNDLE, TRANSCRIPTION FACTOR, TRANSCRIPTION 
2i0j:A   (THR371) to   (MET528)  BENZOPYRANS ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS (SERBAS) WITH NOVEL ACTIVITY IN MODELS OF BENIGN PROSTATIC HYPERPLASIA  |   NUCLEAR RECEPTOR LIGAND BINDING DOMAIN, TRANSCRIPTION 
2i0j:B   (THR371) to   (SER527)  BENZOPYRANS ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS (SERBAS) WITH NOVEL ACTIVITY IN MODELS OF BENIGN PROSTATIC HYPERPLASIA  |   NUCLEAR RECEPTOR LIGAND BINDING DOMAIN, TRANSCRIPTION 
2i0j:D   (THR371) to   (SER527)  BENZOPYRANS ARE SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS (SERBAS) WITH NOVEL ACTIVITY IN MODELS OF BENIGN PROSTATIC HYPERPLASIA  |   NUCLEAR RECEPTOR LIGAND BINDING DOMAIN, TRANSCRIPTION 
4m8h:A   (LEU294) to   (ARG421)  CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH (R)4-METHYL 9CUAB30 AND COACTIVATOR PEPTIDE GRIP- 1  |   ANTIPARALLEL SANDWICH, LIGAND BINDING, COACTIVATOR BINDING, DIMERIZATION, ACTIVATION FUNCTION, TRANSCRIPTION, NUCLEAR RECEPTORS, LIGAND BINDING DOMAIN, LIGAND BINDING POCKET, COACTIVATOR BINDING SITE, CANCER, (R)4-METHYL UAB30 [(2E,4E,6Z,8E)-8-[(4'R)METHYL-3',4'- DIHYDRO-1'(2'H)-NAPHTHALEN-1'-YLIDENE]-3,7-DIMETHYL-2,4,6- OCTATRIENOIC ACID] 
5aau:A   (THR371) to   (SER527)  OPTIMIZATION OF A NOVEL BINDING MOTIF TO TO (E)-3-(3,5- DIFLUORO-4-((1R,3R)-2-(2-FLUORO-2-METHYLPROPYL)-3-METHYL-2, 3,4,9-TETRAHYDRO-1H-PYRIDO(3,4-B)INDOL-1-YL)PHENYL)ACRYLIC ACID (AZD9496), A POTENT AND ORALLY BIOAVAILABLE SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR AND ANTAGONIST  |   SIGNALING PROTEIN, BREAST CANCER, ESTROGEN RECEPTOR DOWNREGULATOR, FULVESTRANT, AZD9496, NUCLEAR HORMONE RECEPTOR 
5aau:B   (THR371) to   (SER527)  OPTIMIZATION OF A NOVEL BINDING MOTIF TO TO (E)-3-(3,5- DIFLUORO-4-((1R,3R)-2-(2-FLUORO-2-METHYLPROPYL)-3-METHYL-2, 3,4,9-TETRAHYDRO-1H-PYRIDO(3,4-B)INDOL-1-YL)PHENYL)ACRYLIC ACID (AZD9496), A POTENT AND ORALLY BIOAVAILABLE SELECTIVE ESTROGEN RECEPTOR DOWNREGULATOR AND ANTAGONIST  |   SIGNALING PROTEIN, BREAST CANCER, ESTROGEN RECEPTOR DOWNREGULATOR, FULVESTRANT, AZD9496, NUCLEAR HORMONE RECEPTOR 
4mg7:B   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH FERUTININE  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
4mg8:A   (LEU372) to   (ASN532)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH ALPHA-ZEARALANOL  |   LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR 
2iok:B  (THR1371) to  (SER1527)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 1D  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ER-ALPHA, ANTAGONIST 
2j4a:A   (CYS298) to   (GLU445)  HUMAN THYROID HORMONE RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH KB131084  |   NUCLEAR PROTEIN, DISEASE MUTATION, NUCLEAR RECEPTOR, ZINC, RECEPTOR, DEAFNESS, ZINC-FINGER, DNA-BINDING, TRANSCRIPTION REGULATION, TRANSCRIPTION, ALTERNATIVE SPLICING, LIGAND BINDING DOMAIN, POLYMORPHISM, METAL-BINDING 
1vjb:B   (SER293) to   (LEU440)  CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE ESTROGEN-RELATED RECEPTOR GAMMA IN COMPLEX WITH 4- HYDROXYTAMOXIFEN  |   LIGAND-BINDING DOMAIN, ANTAGONIST COMPLEX, TRANSCRIPTION 
4n5g:A   (PRO293) to   (LEU436)  CRYSTAL STRUCTURE OF RXRA LBD COMPLEXED WITH A SYNTHETIC MODULATOR K8012  |   RETINOID X RECEPTOR-ALPHA NUCLEAR RECEPTOR, NUCLEUS, SIGNALING PROTEIN 
4n5g:D   (PRO293) to   (LEU436)  CRYSTAL STRUCTURE OF RXRA LBD COMPLEXED WITH A SYNTHETIC MODULATOR K8012  |   RETINOID X RECEPTOR-ALPHA NUCLEAR RECEPTOR, NUCLEUS, SIGNALING PROTEIN 
2jf9:B   (THR371) to   (LYS529)  ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN- SPECIFIC PEPTIDE ANTAGONIST  |   TRANSCRIPTION FACTOR, LIPID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, LIGAND-BINDING DOMAIN (LBD), RECEPTOR, ZINC-FINGER, DNA-BINDING, STEROID-BINDING, NUCLEAR RECEPTOR, PEPTIDE ANTAGONIST, METAL-BINDING, NUCLEAR PROTEIN, PHOSPHORYLATION 
4n8r:A   (LEU294) to   (LEU436)  CRYSTAL STRUCTURE OF RXRA LBD COMPLEXED WITH A SYNTHETIC MODULATOR K- 8008  |   RETINOID X RECEPTOR, ALPHA NUCLEAR RECEPTOR, NUCLEUS, SIGNALING PROTEIN 
4n8r:B   (LEU294) to   (ARG421)  CRYSTAL STRUCTURE OF RXRA LBD COMPLEXED WITH A SYNTHETIC MODULATOR K- 8008  |   RETINOID X RECEPTOR, ALPHA NUCLEAR RECEPTOR, NUCLEUS, SIGNALING PROTEIN 
4n8r:C   (PRO293) to   (GLU434)  CRYSTAL STRUCTURE OF RXRA LBD COMPLEXED WITH A SYNTHETIC MODULATOR K- 8008  |   RETINOID X RECEPTOR, ALPHA NUCLEAR RECEPTOR, NUCLEUS, SIGNALING PROTEIN 
4n8r:D   (PRO293) to   (LEU436)  CRYSTAL STRUCTURE OF RXRA LBD COMPLEXED WITH A SYNTHETIC MODULATOR K- 8008  |   RETINOID X RECEPTOR, ALPHA NUCLEAR RECEPTOR, NUCLEUS, SIGNALING PROTEIN 
1x7b:A   (SER323) to   (HIS475)  CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH ERB-041  |   ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST 
1x7e:A   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH WAY-244  |   ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN RECEPTOR ALPHA, ER-ALPHA, ESTROGEN, NUCLEAR RECEPT TRANSCRIPTION FACTOR, AGONIST 
1kv6:B   (SER293) to   (MET419)  X-RAY STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR ERR3 LIGAND- BINDING DOMAIN IN THE CONSTITUTIVELY ACTIVE CONFORMATION  |   TRANSCRIPTIONALLY ACTIVE CONFORMATION IN ABSENCE OF LIGAND, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS, GENE REGULATION 
2nv7:A   (SER323) to   (ASN483)  CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-555  |   ESTROGEN RECEPTOR, ESTROGEN RECEPTOR BETA, ER-BETA, ER, ESTROGEN, NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, AGONIST, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS INITIATIVE, RSGI 
3jzb:A   (GLU245) to   (GLU391)  CRYSTAL STRUCTURE OF TR-ALFA BOUND TO THE SELECTIVE THYROMIMETIC TRIAC  |   TRIAC, TR, THYROID, ENTROPY, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER 
1lbd:A   (PRO293) to   (HIS435)  LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA  |   TRANSCRIPTION FACTOR, NUCLEAR RECEPTOR, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS 
4oj9:A   (HIS729) to   (LYS883)  CRYSTAL STRUCTURE OF T877A-AR-LBD BOUND WITH CO-REGULATOR PEPTIDE  |   ALPHA-HELIX, HORMONE/GROWTH FACTOR RECEPTOR, PHOSPHORYLATION, HORMONE RECEPTOR-PEPTIDE COMPLEX, SIGNAL TRANSDUCTION 
1xls:A   (PRO293) to   (GLY443)  CRYSTAL STRUCTURE OF THE MOUSE CAR/RXR LBD HETERODIMER BOUND TO TCPOBOP AND 9CRA AND A TIF2 PEPTIDE CONTAING THE THIRD LXXLL MOTIFS  |   LBD, NUCLEAR RECEPTOR, CAR, XENOBIOTIC, TRANSCRIPTION 
1xls:B   (PRO293) to   (GLY443)  CRYSTAL STRUCTURE OF THE MOUSE CAR/RXR LBD HETERODIMER BOUND TO TCPOBOP AND 9CRA AND A TIF2 PEPTIDE CONTAING THE THIRD LXXLL MOTIFS  |   LBD, NUCLEAR RECEPTOR, CAR, XENOBIOTIC, TRANSCRIPTION 
1xls:C   (PRO293) to   (GLY443)  CRYSTAL STRUCTURE OF THE MOUSE CAR/RXR LBD HETERODIMER BOUND TO TCPOBOP AND 9CRA AND A TIF2 PEPTIDE CONTAING THE THIRD LXXLL MOTIFS  |   LBD, NUCLEAR RECEPTOR, CAR, XENOBIOTIC, TRANSCRIPTION 
1xls:D   (PRO293) to   (GLY443)  CRYSTAL STRUCTURE OF THE MOUSE CAR/RXR LBD HETERODIMER BOUND TO TCPOBOP AND 9CRA AND A TIF2 PEPTIDE CONTAING THE THIRD LXXLL MOTIFS  |   LBD, NUCLEAR RECEPTOR, CAR, XENOBIOTIC, TRANSCRIPTION 
1xnx:B   (THR196) to   (SER337)  CRYSTAL STRUCTURE OF CONSTITUTIVE ANDROSTANE RECEPTOR  |   NUCLEAR RECEPTOR; CRYSTAL STRUCTURE, LIGAND RECEPTOR/TRANSRIPTION REGULATION COMPLEX 
4oni:A   (VAL371) to   (GLY524)  STRUCTURE OF HUMAN ORPHAN RECEPTOR LRH1 BOUND TO TWO BACTERIAL PHOSPHOLIPIDS  |   ALPHA HELICAL SANDWICH FOLD, NUCLEAR RECEPTOR, CO-FACTOR BINDING, NUCLEAR PROTEIN 
1xqc:C   (THR371) to   (MET528)  X-RAY STRUCTURE OF ERALPHA LBD BOUND TO A TETRAHYDROISOQUINOLINE SERM LIGAND AT 2.05A RESOLUTION  |   ALPHA-HELICAL SANDWICH, NUCLEAR HORMONE RECEPTOR, LIGAND BINDING DOMAIN 
1xqc:D   (THR371) to   (LEU525)  X-RAY STRUCTURE OF ERALPHA LBD BOUND TO A TETRAHYDROISOQUINOLINE SERM LIGAND AT 2.05A RESOLUTION  |   ALPHA-HELICAL SANDWICH, NUCLEAR HORMONE RECEPTOR, LIGAND BINDING DOMAIN 
2zk1:B   (ASP310) to   (GLU460)  HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN COMPLEXED WITH 15-DEOXY-DELTA12,14- PROSTAGLANDIN J2  |   ANTI PARALLEL HELIX SANDWICH, ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER 
1xv9:B   (ILE187) to   (ILE333)  CRYSTAL STRUCTURE OF CAR/RXR HETERODIMER BOUND WITH SRC1 PEPTIDE, FATTY ACID, AND 5B-PREGNANE-3,20-DIONE.  |   CAR, RXR, SRC1, PREGNANEDIONE, DNA BINDING PROTEIN 
1xv9:C   (PRO293) to   (LYS440)  CRYSTAL STRUCTURE OF CAR/RXR HETERODIMER BOUND WITH SRC1 PEPTIDE, FATTY ACID, AND 5B-PREGNANE-3,20-DIONE.  |   CAR, RXR, SRC1, PREGNANEDIONE, DNA BINDING PROTEIN 
1xv9:D   (PRO186) to   (ILE333)  CRYSTAL STRUCTURE OF CAR/RXR HETERODIMER BOUND WITH SRC1 PEPTIDE, FATTY ACID, AND 5B-PREGNANE-3,20-DIONE.  |   CAR, RXR, SRC1, PREGNANEDIONE, DNA BINDING PROTEIN 
1m7w:C   (LEU204) to   (GLY353)  HNF4A LIGAND BINDING DOMAIN WITH BOUND FATTY ACID  |   TRANSCRIPTION FACTOR 
1xvp:A   (PRO293) to   (LYS440)  CRYSTAL STRUCTURE OF CAR/RXR HETERODIMER BOUND WITH SRC1 PEPTIDE, FATTY ACID AND CITCO  |   CAR, RXR, CITCO, SRC1, DNA BINDING PROTEIN 
1xvp:B   (ILE187) to   (ILE333)  CRYSTAL STRUCTURE OF CAR/RXR HETERODIMER BOUND WITH SRC1 PEPTIDE, FATTY ACID AND CITCO  |   CAR, RXR, CITCO, SRC1, DNA BINDING PROTEIN 
1xvp:C   (PRO293) to   (LYS440)  CRYSTAL STRUCTURE OF CAR/RXR HETERODIMER BOUND WITH SRC1 PEPTIDE, FATTY ACID AND CITCO  |   CAR, RXR, CITCO, SRC1, DNA BINDING PROTEIN 
4ozr:U   (ILE227) to   (LYS364)  CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAINS OF THE BOVICOLA OVIS ECDYSONE RECEPTOR ECR/USP HETERODIMER (METHYLENE LACTAM CRYSTAL)  |   ECDYSONE RECEPTOR, USP, METHYLENE LACTAM, HETERODIMER, LIGAND BINDING DOMAIN, TRANSCRIPTION 
1yin:A   (THR371) to   (SER527)  HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 3F  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, ER-ALPHA, ANTAGONIST, HORMONE/GROWTH FACTOR RECEPTOR COMPLEX 
1mzn:E  (PRO2293) to  (ILE2442)  CRYSTAL STRUCTURE AT 1.9 ANGSTROEMS RESOLUTION OF THE HOMODIMER OF HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE  |   TRANSCRIPTION, NUCLEAR RECEPTOR, RETINOIC ACID RECEPTORS, AGONIST 
3a9e:A   (PRO298) to   (LEU441)  CRYSTAL STRUCTURE OF A MIXED AGONIST-BOUND RAR-ALPHA AND ANTAGONIST- BOUND RXR-ALPHA HETERODIMER LIGAND BINDING DOMAINS  |   TRANSCRIPTION, NUCLEUS, RECEPTOR, TRANSCRIPTION REGULATION, STRUCTURAL GENOMICS, SPINE2-COMPLEXES, STRUCTURAL PROTEOMICS IN EUROPE 
5di7:A   (LEU379) to   (ASN532)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH AN METHYL-SUBSTITUTED A-CD RING ESTROGEN DERIVATIVE (1S,3AR,5S, 7AS)-5-(4-HYDROXY-2-METHYLPHENYL)-7A-METHYLOCTAHYDRO-1H-INDEN-1-OL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5di7:B   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH AN METHYL-SUBSTITUTED A-CD RING ESTROGEN DERIVATIVE (1S,3AR,5S, 7AS)-5-(4-HYDROXY-2-METHYLPHENYL)-7A-METHYLOCTAHYDRO-1H-INDEN-1-OL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5did:B   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DIFLUORO-SUBSTITUTED A-CD RING ESTROGEN DERIVATIVE (1S,3AR,5S, 7AS)-5-(2,3-DIFLUORO-4-HYDROXYPHENYL)-7A-METHYLOCTAHYDRO-1H-INDEN-1- OL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dig:B   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A TRIFLUOROMETHYL-SUBSTITUTED A-CD RING ESTROGEN DERIVATIVE (1S, 3AR,5S,7AS)-5-[4-HYDROXY-2-(TRIFLUOROMETHYL)PHENYL]-7A- METHYLOCTAHYDRO-1H-INDEN-1-OL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dk9:A   (VAL364) to   (LYS529)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A PHENYLAMINO-SUBSTITUTED ETHYL TRIARYL-ETHYLENE DERIVATIVE 4, 4'-{2-[3-(PHENYLAMINO)PHENYL]BUT-1-ENE-1,1-DIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dke:A   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 3-NAPHTHYL-SUBSTITUTED, METHYL, CIS-DIARYL-ETHYLENE COMPOUND 4,4'-[2-(NAPHTHALEN-2-YL)PROP-1-ENE-1,1-DIYL]DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
4pld:A   (LYS370) to   (GLY524)  HUMAN NUCLEAR RECEPTOR LIVER RECEPTOR HOMOLOGUE-1, LRH-1, IN ITS APO STATE BOUND TO A FRAGMENT OF HUMAN TIF-2  |   NUCLEAR RECEPTOR, APO, TRANSCRIPTION 
1z5x:E   (GLY247) to   (ASN401)  HEMIPTERAN ECDYSONE RECEPTOR LIGAND-BINDING DOMAIN COMPLEXED WITH PONASTERONE A  |   ECDYSONE RECEPTOR, PONASTERONE A, NUCLEAR RECEPTOR, ECR, USP, ECDYSONE, HORMONE/GROWTH FACTOR RECEPTOR COMPLEX 
1zdt:B   (VAL291) to   (ASN444)  THE CRYSTAL STRUCTURE OF HUMAN STEROIDOGENIC FACTOR-1  |   STEROIDOGENIC FACTOR-1, NUCLEAR RECEPTOR, PHOLPHOLIPID, PHOSPHATIDYLETHANOLAMINE, TRANSCRIPTION 
5du5:B   (LEU372) to   (LYS531)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DICHLORO-SUBSTITUTED, 3,4-DIARYLTHIOPHENE DIOXIDE CORE LIGAND  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dug:A   (LEU372) to   (ASN532)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A SULFOXIDE-BRIDGED OXABICYCLIC HEPTENE SULFONATE (SOBHS)-2 ANALOG PHENYL (1S,2S,4S,7S)-5,6-BIS(4-HYDROXY-2-METHYLPHENYL)-7- THIABICYCLO[2.2.1]HEPT-5-ENE-2-SULFONATE 7-OXIDE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dug:B   (LEU372) to   (ASN532)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A SULFOXIDE-BRIDGED OXABICYCLIC HEPTENE SULFONATE (SOBHS)-2 ANALOG PHENYL (1S,2S,4S,7S)-5,6-BIS(4-HYDROXY-2-METHYLPHENYL)-7- THIABICYCLO[2.2.1]HEPT-5-ENE-2-SULFONATE 7-OXIDE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
1zh7:A   (VAL390) to   (VAL541)  STRUCTURAL AND BIOCHEMICAL BASIS FOR SELECTIVE REPRESSION OF THE ORPHAN NUCLEAR RECEPTOR LRH-1 BY SHP  |   PROTEIN-PEPTIDE COMPLEX, TRANSCRIPTION 
1zh7:B   (VAL390) to   (GLY543)  STRUCTURAL AND BIOCHEMICAL BASIS FOR SELECTIVE REPRESSION OF THE ORPHAN NUCLEAR RECEPTOR LRH-1 BY SHP  |   PROTEIN-PEPTIDE COMPLEX, TRANSCRIPTION 
5dwi:A   (THR371) to   (LYS531)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A RESORCINYL 2-CHLORO-SUBSTITUTED DIARYL-IMINE ANALOG 4-[(E)- [(2-CHLOROPHENYL)IMINO](4-HYDROXYPHENYL)METHYL]BENZENE-1,3-DIOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dwi:B   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A RESORCINYL 2-CHLORO-SUBSTITUTED DIARYL-IMINE ANALOG 4-[(E)- [(2-CHLOROPHENYL)IMINO](4-HYDROXYPHENYL)METHYL]BENZENE-1,3-DIOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dxr:A   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[(3R)-3- METHYLCYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dxr:B   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[(3R)-3- METHYLCYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dy8:A   (THR371) to   (LYS529)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[(3S)-3- ETHYLCYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dyd:B   (THR371) to   (LYS529)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[(3S)-3-(METHYLSULFANYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dz3:A   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[4-(FLUOROMETHYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5dzi:B   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[(3S)-3-(2-HYDROXYETHYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5e0w:A   (THR371) to   (CYS530)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[(3S)-3-(4-HYDROXYPHENYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5e0w:B   (THR371) to   (SER527)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[(3S)-3-(4-HYDROXYPHENYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
4q50:G   (THR371) to   (MET528)  THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN D538G MUTANT IN COMPLEX WITH 4-HYDROXYTAMOXIFEN  |   ACQUIRED SERM-RESISTANCE, BREAST CANCER, ACTIVATING MUTATION, SERM-ER STRUCTURE, ALPHA HELIX, NUCLEAR HORMONE RECEPTOR, HORMONE BINDING PROTEIN 
2acl:G   (PRO293) to   (LEU433)  LIVER X-RECEPTOR ALPHA LIGAND BINDING DOMAIN WITH SB313987  |   NUCLEAR HORMONE RECEPTOR LIGAND BINDING DOMAIN TRANSCRIPTION FACTOR THREE LAYERED A-HELIX FOLD 
4rak:A   (GLY296) to   (SER436)  CRYSTAL STRUCTURE OF NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2 (LXRB) COMPLEXED WITH PARTIAL AGONIST  |   NHR, NR1H2, LXR-B, LXRB, UNR, NER-I, RIP15, NER, LIGAND BINDING DOMAIN, NUCLEAR HORMONE RECEPTOR, RXR, TRANSCRIPTION-AGONIST COMPLEX 
3noa:B   (LEU311) to   (LYS458)  CRYSTAL STRUCTURE OF HUMAN PPAR-GAMMA LIGAND BINDING DOMAIN COMPLEX WITH A POTENCY IMPROVED AGONIST  |   HYPOGLYCEMIC AGENTS, MODELS, MOLECULAR, PPAR ALPHA, PPAR GAMMA, PROTEIN ISOFORMS, QUINOLINES, STRUCTURE-ACTIVITY RELATIONSHIP, THIAZOLIDINEDIONES, TRANSCRIPTION 
3nsq:A   (PRO293) to   (GLU434)  CRYSTAL STRUCTURE OF TETRAMERIC RXRALPHA-LBD COMPLEXED WITH ANTAGONIST DANTHRON  |   NUCLEAR RECEPTOR RETINOIC X RECEPOR ALPHA LIGAND BINDING DOMAIN ANTAGONIST DANTHRON, TRANSCRIPTION 
3ctb:A   (PRO268) to   (PRO419)  TETHERED PXR-LBD/SRC-1P APOPROTEIN  |   PXR,SRC-1, TETHERED, ENGINEERED, DRUG-DRUG INTERACTIONS, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION REGULATION, ZINC- FINGER, TRANSCRIPTION, TRANSFERASE 
3ctb:B   (PRO268) to   (HIS418)  TETHERED PXR-LBD/SRC-1P APOPROTEIN  |   PXR,SRC-1, TETHERED, ENGINEERED, DRUG-DRUG INTERACTIONS, DNA-BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION REGULATION, ZINC- FINGER, TRANSCRIPTION, TRANSFERASE 
4s0t:B   (LEU240) to   (HIS418)  STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN BOUND WITH ADNECTIN-1 AND COMPOUND-1  |   NUCLEAR RECEPTOR, MULTIPLE BINDING MODES, XENOBIOTIC, PROMISCUOUS, NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION 
3d24:A   (SER253) to   (LEU383)  CRYSTAL STRUCTURE OF LIGAND-BINDING DOMAIN OF ESTROGEN- RELATED RECEPTOR ALPHA (ERRALPHA) IN COMPLEX WITH THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR COACTIVATOR- 1ALPHA BOX3 PEPTIDE (PGC-1ALPHA)  |   NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, COACTIVATOR, DNA- BINDING, METAL-BINDING, NUCLEUS, PHOSPHOPROTEIN, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, POLYMORPHISM, RNA-BINDING, STRUCTURAL GENOMICS, STRUCTURAL PROTEOMICS IN EUROPE, SPINE 
4tuz:A   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH ALPHA-ZEARALENOL  |   NUCLEAR HORMONE RECEPTOR LIGAND BINDING DOMAIN ENDOCRINE DISRUPTOR ENVIRONMENTAL COMPOUND, NUCLEAR PROTEIN 
4tv1:B   (THR371) to   (LYS531)  CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH PROPYLPARABEN  |   NUCLEAR HORMONE RECEPTOR, LIGAND BINDING DOMAIN, ENDOCRINE DISRUPTOR, ENVIRONMENTAL COMPOUND, HORMONE RECEPTOR 
5hjp:A   (PRO364) to   (GLY514)  IDENTIFICATION OF LXRBETA SELECTIVE AGONISTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE  |   AGONIST, ALZHEIMER'S, SIGNALING PROTEIN 
5hjp:D   (GLY296) to   (ARG411)  IDENTIFICATION OF LXRBETA SELECTIVE AGONISTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE  |   AGONIST, ALZHEIMER'S, SIGNALING PROTEIN 
4dma:B  (THR1371) to  (ASN1532)  CRYSTAL STRUCTURE OF ERA LBD IN COMPLEX WITH RU100132  |   TRANSCRIPTION, NUCLEAR RECEPTOR, ER, ESTROGEN RECEPTOR, ALPHA HELICAL SANDWICH, TRANSCRIPTION FACTOR, ESTRADIOL, TRANSCRIPTION-PROTEIN BINDING-AGONIST COMPLEX 
3pcu:A   (PRO293) to   (GLY443)  CRYSTAL STRUCTURE OF HUMAN RETINOIC X RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED WITH LX0278 AND SRC1 PEPTIDE  |   NUCLEAR RECEPTOR RXRALPHA, LIGAND-BINDING DOMAIN, TRANSCRIPTION- TRANSCRIPTION REGULATOR COMPLEX 
5i4v:A   (GLY296) to   (ASP446)  DISCOVERY OF NOVEL, ORALLY EFFICACIOUS LIVER X RECEPTOR (LXR) BETA AGONISTS  |   LXRBETA-LBD, RXRBETA-LBD, HETERODIMER, AGONIST, DNA BINDING PROTEIN 
5i4v:E   (GLY296) to   (ARG411)  DISCOVERY OF NOVEL, ORALLY EFFICACIOUS LIVER X RECEPTOR (LXR) BETA AGONISTS  |   LXRBETA-LBD, RXRBETA-LBD, HETERODIMER, AGONIST, DNA BINDING PROTEIN 
3plz:B   (VAL371) to   (GLY524)  HUMAN LRH1 LBD BOUND TO GR470  |   ALPHA HELICAL SANDWHICH, NUCLEAR RECEPTOR, FAMILY FIVE, TRANSCRIPTION FACTOR, CO-ACTIVATOR, TRANSCRIPTION-RECEPTOR-AGONIST COMPLEX 
4fhi:A   (THR283) to   (PRO434)  DEVELOPMENT OF SYNTHETICALLY ACCESSIBLE NON-SECOSTEROIDAL HYBRID MOLECULES COMBINING VITAMIN D RECEPTOR AGONISM AND HISTONE DEACETYLASE INHIBITION  |   LIGAND BINDING DOMAIN ALPHA HELICAL SANDWICH, ALPHA HELICAL SANDWICH, TRANSCRIPTION FACTOR, DNA COREGULATORS, PHOSPHORYLATION, NUCLEUS, TRANSCRIPTION-PROTEIN BINDING-INHIBITOR COMPLEX 
3r29:A   (PRO293) to   (LEU441)  CRYSTAL STRUCTURE OF RXRALPHA LIGAND-BINDING DOMAIN COMPLEXED WITH COREPRESSOR SMRT2  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING DOMAIN, TRANSCRIPTION 
3r8d:A   (PRO268) to   (HIS418)  ACTIVATION OF THE HUMAN NUCLEAR XENOBIOTIC RECEPTOR PXR BY THE REVERSE TRANSCRIPTASE-TARGETED ANTI-HIV DRUG PNU-142721  |   NUCLEAR RECEPTOR, PXR, XENOBIOTIC, LIGAND BINDING DOMAIN, TRANSCRIPTION REGULATION, XENOBIOTICS, ENDOBIOTICS, TRANSCRIPTION 
4g20:A   (THR283) to   (GLN433)  STRUCTURAL BASIS FOR THE ACCOMMODATION OF BIS- AND TRIS-AROMATIC DERIVATIVES IN VITAMIN D NUCLEAR RECEPTOR  |   VDR, TRANSCRIPTION REGULATION, NUCLEAR RECEPTOR, ALPHA HELICAL SANDWICH, LIGAND, DNA, PHOSPHORYLATION, NUCLEUS, TRANSCRIPTION- TRANSCRIPTION INHIBITOR COMPLEX 
5jy3:A   (GLY296) to   (SER436)  CRYSTAL STRUCTURE OF LXRBETA (NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2) COMPLEXED WITH BMS-852927  |   NHR, NR1H2, LXR-B, LXRB, UNR, NER-I, RIP15, NER, TRANSCRIPTION 
5kcc:A   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH OXABICYCLIC HEPTENE SULFONAMIDE (OBHS-N)  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
5kce:A   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-METHYL, 2-CHLOROBENZYL OBHS-N DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, SIGNALING PROTEIN, TRANSCRIPTION 
5kd9:B   (VAL364) to   (SER527)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-TRIFLUOROETHYL 4-CHLOROBENZYL OBHS-N DERIVATIVE  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
1a52:A   (LEU379) to   (LYS531)  ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO ESTRADIOL  |   RECEPTOR, ESTROGEN, LIGAND, TRANSCRIPTION REGULATION 
2qmv:A   (ASP310) to   (LYS458)  HIGH RESOLUTION STRUCTURE OF PEROXISONE PROLIFERATION-ACTIVATED RECEPTOR GAMMA AND CHARACTERISATION OF ITS INTERACTION WITH THE CO- ACTIVATOR TRANSCRIPTIONAL INTERMEDIARY FACTOR 2  |   PEROXISOME PROFILERATION ACTIVATED RECEPTOR GAMMA, PPARG, TRANSCRIPTIONAL INTERMEDIARY FACTOR 2 (TIF2), PROTEIN STRUCTURE, ACTIVATOR, DIABETES MELLITUS, DISEASE MUTATION, DNA-BINDING, METAL- BINDING, NUCLEUS, OBESITY, PHOSPHORYLATION, TRANSCRIPTION REGULATION, ZINC-FINGER, TRANSCRIPTION REGULATOR 
1pk5:A   (LYS389) to   (GLY543)  CRYSTAL STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR LRH-1  |   NUCLEAR RECEPTOR, LIGAND-BINDING DOMAIN, LRH-1, GENE REGULATION 
1pk5:B   (LYS389) to   (GLY543)  CRYSTAL STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR LRH-1  |   NUCLEAR RECEPTOR, LIGAND-BINDING DOMAIN, LRH-1, GENE REGULATION 
1q4x:A   (CYS298) to   (CYS446)  CRYSTAL STRUCTURE OF HUMAN THYROID HORMONE RECEPTOR BETA LBD IN COMPLEX WITH SPECIFIC AGONIST GC-24  |   CONFORMATIONAL CHANGE IN TWO FRAMEWORK HELICES UPON LIGAND BINDING, TRANSCRIPTION 
1fm6:A   (PRO293) to   (LEU441)  THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES.  |   THE HETERODIMER OF THE NUCLEAR RECEPTOR LIGAND BINDING DOMAINS OF RXRALPHA AND PPARGAMMA BOUND RESPECTIVELY WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES, TRANSCRIPTION 
1fm6:U   (PRO293) to   (ILE442)  THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES.  |   THE HETERODIMER OF THE NUCLEAR RECEPTOR LIGAND BINDING DOMAINS OF RXRALPHA AND PPARGAMMA BOUND RESPECTIVELY WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES, TRANSCRIPTION 
4kzm:B   (SER431) to   (GLU579)  CRYSTAL STRUCTURE OF TR3 LBD S553A MUTANT  |   ORPHAN NUCLEAR RECEPTOR, TRANSCRIPTION 
4lnw:A   (ASP246) to   (GLU391)  CRYSTAL STRUCTURE OF TR-ALPHA BOUND TO T3 IN A SECOND SITE  |   MAINLY ALPHA ORTHOGONAL BUNDLE, TRANSCRIPTION FACTOR, TRANSCRIPTION 
3k6p:A   (SER349) to   (TYR496)  ESTROGEN RELATED RECEPTOR ALPHA IN COMPLEX WITH AN ETHER BASED LIGAND  |   ESTROGEN RELATED RECEPTOR ALPHA, DNA-BINDING, ISOPEPTIDE BOND, METAL- BINDING, NUCLEUS, PHOSPHOPROTEIN, RECEPTOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC-FINGER, HORMONE RECEPTOR 
1n46:A   (CYS298) to   (GLU445)  CRYSTAL STRUCTURE OF HUMAN TR BETA LIGAND-BINDING DOMAIN COMPLEXED WITH A POTENT SUBTYPE-SELECTIVE THYROMIMETIC  |   TRANSCRIPTION 
5dkb:A   (THR371) to   (LYS529)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 3-METHYLPHENYLAMINO-SUBSTITUTED ETHYL TRIARYL-ETHYLENE DERIVATIVE 4,4'-(2-{3-[(3-METHYLPHENYL)AMINO]PHENYL}BUT-1-ENE-1,1- DIYL)DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
4pps:A   (THR371) to   (ASN532)  CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH AN A-CD RING ESTROGEN DERIVATIVE  |   NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING, NUCLEUS, PROTEIN BINDING 
5e14:A   (THR371) to   (TYR526)  CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4'-{[(3R)-3- PHENYLCYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND BINDING, PROTEIN- LIGAND COMPLEX, TRANSCRIPTION 
4re8:B   (SER100) to   (ASP249)  CRYSTAL STRUCTURE OF TR3 LBD IN COMPLEX WITH MOLECULE 5  |   LBD, TRANSCRIPTION 
4rze:B   (SER100) to   (ASP249)  CRYSTAL STRUCTURE ANALYSIS OF THE NUR77 LIGAND BINDING DOMAIN, L437W, D594E MUTANT  |   TRANSCRIPTION 
4rzf:B   (SER100) to   (ASP249)  CRYSTAL STRUCTURE ANALYSIS OF THE NUR77 LIGAND BINDING DOMAIN, S441W MUTANT  |   TRANSCRIPTION 
3r2a:A   (PRO293) to   (GLY443)  CRYSTAL STRUCTURE OF RXRALPHA LIGAND-BINDING DOMAIN COMPLEXED WITH COREPRESSOR SMRT2 AND ANTAGONIST RHEIN  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING DOMAIN, TRANSCRIPTION 
3r2a:C   (PRO293) to   (GLY443)  CRYSTAL STRUCTURE OF RXRALPHA LIGAND-BINDING DOMAIN COMPLEXED WITH COREPRESSOR SMRT2 AND ANTAGONIST RHEIN  |   NUCLEAR RECEPTOR, TRANSCRIPTION FACTOR, LIGAND-BINDING DOMAIN, TRANSCRIPTION